Effects of clofazimine alone or combined with dapsone on neutrophil and lymphocyte functions in normal individuals and patients with lepromatous leprosy
- 1 May 1982
- journal article
- clinical trial
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 21 (5) , 693-697
- https://doi.org/10.1128/aac.21.5.693
Abstract
The effects of clofazimine on neutrophil activities such as random motility, migration to the leukoattractants endotoxin-activated serum and N-formyl-L-methionyl-L-leucyl-L-phenylalanine phagocytosis of Candida albicans, postphagocytic hexose-monophosphate shunt activity, and myeloperoxidase-mediated iodination and the effects of clofazimine on lymphocyte transformation to mitogens were assessed in vitro and after ingestion of the drug by normal individuals and patients with lepromatous leprosy. For in vitro studies, the concentration range of the drug investigated was 10(-6) M to 10(-2) M. for in vivo studies, subjects ingested 200 mg of clofazimine daily for a period of 5 days. At concentrations of 5 X 10(-6) M to 5 X 10(-3) M clofazimine caused a progressive dose-dependent inhibition of neutrophil motility without detectable effects on phagocytosis, postphagocytic hexose-monophosphate shunt activity, or myeloperoxidase-mediated iodination. Over the same concentration range, clofazimine inhibited lymphocyte transformation. The inhibitory effect on neutrophil motility was associated with a spontaneous stimulation of oxidative metabolism and could be prevented by coincubation of dapsone with clofazimine. after ingestion of clofazimine responsiveness of lymphocytes to mitogens was decreased in normal volunteers and leprosy patients: neutrophil motility in normal individuals was likewise inhibited.Keywords
This publication has 17 references indexed in Scilit:
- Stimulation of Macrophage Phagocytosis by ClofazimineScandinavian Journal of Haematology, 2009
- In vitro and in vivo effects of dapsone on neutrophil and lymphocyte functions in normal individuals and patients with lepromatous leprosyAntimicrobial Agents and Chemotherapy, 1981
- In vivoeffects of propranolol on some cellular and humoral immune functions in a group of patients with lepromatous leprosyLeprosy Review, 1980
- Dapsone*Clinical and Experimental Dermatology, 1979
- Lamprene (Clofazimine) in LeprosyLeprosy Review, 1979
- Myeloperoxidase-Mediated Iodination by Granulocytes INTRACELLULAR SITE OF OPERATION AND SOME REGULATING FACTORSJournal of Clinical Investigation, 1974
- Forty-four Months' Experience in the Treatment of Leprosy with Clofazimine (Lamprene (Geigy))Leprosy Review, 1971
- The Experimental Properties of G 30 320 (B 663) - a New Anti-leprotic AgentLeprosy Review, 1969
- A Treatment of Corticosteroid-Dependent Lepromatous Patients in Persistent Erythema Nodosum Leprosum - A Clinical Evaluation of G. 30320 (B663)Leprosy Review, 1968
- A New Series of Phenazines (Rimino-Compounds) With High Antituberculosis ActivityNature, 1957